Fox 13 – May 3
Kelviyana heads to the University of Florida in the fall. She recently received a scholarship from the Moffitt Cancer Center. She plans to become an oncologist, maybe a cancer researcher, so that she can help other women just like her mom. Armwood's collegiate program is one of three in the district.
Tampa Bay Times – May 3
All 10 of the high school seniors recognized by the 2018 Moffitt Healthy KIDZ Role Model program offered stories of perseverance, community care and faithful families. They’ll begin their higher education pursuits with a $2,000 scholarship and an eye towards a career in the STEM field.
Tampa Bay Business Journal – May 3
Morphogenesis Inc., an immunotherapy company that’s just raised $16 million to back its work developing a treatment for cancer, is settling into its new headquarters at 10500 University Center Drive. The 12,000-square-foot headquarters is less than a mile from Moffitt’s outpatient center, where patients in Morphogenesis’ planned clinical trial would be treated, said Patricia Lawman, CEO.
NewsMedical.net – May 3
While prevention and screening are keys to driving down those statistics, better understanding of skin cancer, including what causes and drives it are a big focus of the Donald A. Adam Melanoma and Skin Cancer Center of Excellence at Moffitt Cancer Center.
Tampa Bay Business Journal – May 2
The new capital will allow Morphogenesis to hire more scientists, Patel said, as well as fund human clinical trials at Moffitt Cancer Center in Tampa and develop its executive management team.
NBC News – May 1
“It’s impossible at this juncture to tell what causes this," said Dr. Jonathan Zager, surgical oncologist and director of Regional Therapies in the Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center in Tampa, Florida. "Suspected contributors include BAP1 mutations and possibly a small link to sun exposure.”
Associated Press – May 2
“It’s a real arms race,” said Johnstone, the former proton-center CEO, who has co-authored papers on proton-therapy economics. He is now vice chair of radiation oncology at Moffitt Cancer Center in Tampa, which doesn’t have a proton center. “What places need now are patients — a huge supply of patients.” Also posted on Medical Health News, St. Louis Post Dispatch, Philly Voice
Delta Sky Magazine – May 2018
Alan List, M.D.: I was recruited in 2003 to lead the center’s Malignant Hematology program. Today, I’m president and CEO.
Technology Networks – May 2
The Florida Department of Health's James and Esther King Biomedical Research Program has armed Moffitt Cancer Center, University of Florida (UF) Health Cancer Center - Gainesville, Sylvester Comprehensive Cancer Center at the University of Miami and numerous collaborating centers with $1.36 million to address cancer disparities and improve outcomes and care for individuals affected by pancreatic cancer.
Cure Magazine – May 1
Her doctors at H. Lee Moffitt Cancer Center in Tampa, Florida, determined that another course of chemotherapy wasn’t an option. But Koziar-Jordan was fortunate because during the time she was fighting her cancer, scientists around the world were developing newer forms of immunotherapy — drugs that can train the immune system to recognize and eliminate tumors.
Oanow.com – May 1
Susan Story, a 1981 graduate and president and CEO of American Water Works, will speak at both Saturday ceremonies…She also serves on the Moffitt Cancer Center Board of Advisors.
Medical Health News – April 30
According to the lead author, Frederick L. Locke, MD, of the Moffitt Cancer Center in Tampa, Florida, there are plans to move to a phase 2 study.
OncLive – April 30
Hatem Soliman, MD, medical oncologist, The Center for Women’s Oncology, Moffitt Cancer Center, discusses the use of combination therapies in the treatment of patients with breast cancer.
Science Daily – April 30
Researchers at Moffitt Cancer Center are using mathematical modeling based on evolutionary principles to show that adaptive drug treatments based on tumor responses to prior treatment are more effective than maximum-tolerated dose approaches for certain tumor situations.
MedicalXpress.com – April 30
"An evolutionary flaw in this maximum-tolerated dose strategy is the assumption that resistant populations are not present prior to therapy. It is now clear that cancer cells can be insensitive even to treatment that they have never seen before," explained study author Jill Gallaher, Ph.D., an applied research scientist in the Department of Integrated Mathematical Oncology at Moffitt.
ASH Clinical News – April 30
This finding could have important clinical implications for treatment of patients who present with CHIP at the time of primary cancer diagnosis, the study’s lead author Nancy K. Gillis, PharmD, postdoctoral fellow at the Moffitt Cancer Center in Florida, told ASH Clinical News.
Sun Sentinel – April 28
Proceeds from the event will go to beneficiaries such as Melanoma Research at Moffitt Cancer Center, The Dermatology Clinic at The Caridad Center, The League of Ribbons at Lynn Cancer Institute, Dermatology Medical Missions, and The Richard David Kann Melanoma Foundation.
Fox News – April 28
Every few months, I walk into Moffitt Cancer Center in Tampa, Florida, where I cross paths with brave women ravaged by chemotherapy, women whose situations are far direr than my own. Always the youngest one in the room, I wait alongside these cancer patients for my preventative screening, praying their battle will not become my own.
Jamaica Observer – April 30
The H Lee Moffitt Cancer Center & Research Institute where this procedure was developed has successfully carried out over 5,000 of this type of transplant.
Osprey Observer – April 27
The newly expanded program offers the following areas of work-training: … Medical Services-Courses offered help students learn skills like medical support, Moffitt Cancer Center support, and medical policy compliance.
TBO.com – April 26
Jean-Pierre Coy revealed her story to the audience of more than 800. The event brought together two entities that honor George Edgecomb: the bar and the George Edgecomb Society, formed by Moffitt in 2016 to raise funds towards the study of racial disparities in cancer treatment.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.